Literature DB >> 10191802

The effects on fetal development of high alpha-fetoprotein and maternal smoking.

S Heinonen1, M Ryynänen, P Kirkinen.   

Abstract

OBJECTIVES: This study determined the risk of impaired fetal growth resulting from the interaction between maternal smoking during pregnancy and unexplained elevated concentrations of maternal serum alpha-fetoprotein (MSAFP).
METHODS: This observational study involved 123 pregnant smokers with unexplained second-trimester elevated concentrations of MSAFP, 827 smokers with normal levels, and 471 nonsmokers with raised levels.
RESULTS: By logistic regression, coincident smoking and elevated MSAFP levels were found to be associated with increases in the low basic risks of prematurity, small-for-gestational-age births, low birthweight, and need for neonatal care.
CONCLUSIONS: Maternal smoking has an adverse effect on fetal development in pregnancies with unexplained elevated MSAFP concentrations. Such pregnancies merit close surveillance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191802      PMCID: PMC1508907          DOI: 10.2105/ajph.89.4.561

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  15 in total

1.  Mid-trimester levels of alphafetoprotein in the screening of low birthweight.

Authors:  T Chard; A Rice; M J Kitau; V Hird; J G Grudzinskas; A M Nysenbaum
Journal:  Br J Obstet Gynaecol       Date:  1986-01

2.  Outcome in infants born to mothers with unexplained elevations of maternal serum alpha-fetoprotein.

Authors:  B K Burton; R G Dillard
Journal:  Pediatrics       Date:  1986-04       Impact factor: 7.124

3.  Elevated maternal serum alpha-fetoprotein levels and oligohydramnios: poor prognosis for pregnancy outcome.

Authors:  S N Dyer; B K Burton; L H Nelson
Journal:  Am J Obstet Gynecol       Date:  1987-08       Impact factor: 8.661

4.  Pregnancy outcomes after increasing maternal serum alpha-fetoprotein levels.

Authors:  L Robinson; P Grau; B F Crandall
Journal:  Obstet Gynecol       Date:  1989-07       Impact factor: 7.661

Review 5.  Determinants of low birth weight: methodological assessment and meta-analysis.

Authors:  M S Kramer
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

6.  Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.

Authors:  A Milunsky; S S Jick; C L Bruell; D S MacLaughlin; Y K Tsung; H Jick; K J Rothman; W Willett
Journal:  Am J Obstet Gynecol       Date:  1989-08       Impact factor: 8.661

7.  Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.

Authors:  S Heinonen; M Ryynänen; P Kirkinen; I Penttilä; K Syrjänen; M Seppälä; S Saarikoski
Journal:  Prenat Diagn       Date:  1996-03       Impact factor: 3.050

8.  Effects on birth weight of smoking, alcohol, caffeine, socioeconomic factors, and psychosocial stress.

Authors:  O G Brooke; H R Anderson; J M Bland; J L Peacock; C M Stewart
Journal:  BMJ       Date:  1989-03-25

9.  Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein.

Authors:  B K Burton
Journal:  Obstet Gynecol       Date:  1988-11       Impact factor: 7.661

10.  Maternal serum-alpha-fetoprotein measurements as an early indicator of low birth-weight.

Authors:  D J Brock; L Barron; P Jelen; M Watt; J B Scrimgeour
Journal:  Lancet       Date:  1977-08-06       Impact factor: 79.321

View more
  2 in total

Review 1.  Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis.

Authors:  Rachel K Morris; Jeltsje S Cnossen; Marloes Langejans; Stephen C Robson; Jos Kleijnen; Gerben Ter Riet; Ben W Mol; Joris A M van der Post; Khalid S Khan
Journal:  BMC Pregnancy Childbirth       Date:  2008-08-04       Impact factor: 3.007

2.  Effects of alcohol, cigarettes, methamphetamine and marijuana exposure during pregnancy on maternal serum alpha-fetoprotein levels at 20-24 weeks'gestation.

Authors:  H J Odendaal; L Geerts; D G Nel; L T Brink; E Hitchcock; C A Groenewald
Journal:  J Pediatr Neonatal Care       Date:  2018-02-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.